Evidence map›Paper›PMID 41697568›Full record

ReviewJournal of physiology and biochemistry2026

From molecular mechanisms to nutritional applications: protein and polyphenol interventions in sarcopenia.

Patricia Aragón-Espinosa, Patricia Pérez-Matute, Catherine Bompart, Marine Gueugneau, Frederic Capel, Jose M Arbones-Mainar, Saioa Gomez-Zorita, Anna Mas-Capdevila, Xavier Escoté, Montserrat Pinent and 1 more

Abstract readReview
In one paragraph

Review in Journal of physiology and biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Patricia Aragón-Espinosa *Lifestyle, Microbiota and Health Group. Health Sciences Faculty, University of La Rioja, Logroño, La Rioja, 26003, Spain.
Patricia Pérez-Matute *Lifestyle, Microbiota and Health Group. Health Sciences Faculty, University of La Rioja, Logroño, La Rioja, 26003, Spain.
Catherine BompartUnité de Nutrition Humaine, Université Clermont Auvergne, INRAE, Clermont-Ferrand, 63000, France.
Marine GueugneauUnité de Nutrition Humaine, Université Clermont Auvergne, INRAE, Clermont-Ferrand, 63000, France.
Frederic CapelUnité de Nutrition Humaine, Université Clermont Auvergne, INRAE, Clermont-Ferrand, 63000, France.
Jose M Arbones-MainarCIBER in Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, 28029, Spain.
Saioa Gomez-ZoritaCIBER in Physiopathology of Obesity and Nutrition (CIBEROBN), Carlos III Health Institute, Madrid, 28029, Spain.
Anna Mas-CapdevilaEurecat, Technological Unit of Nutrition and Health, Centre Tecnològic de Catalunya, Avinguda Universitat 1, Reus, Catalonia, 43204, Spain.
Xavier EscotéUniversitat Rovira I Virgili ( Department Biochemistry and Biotechnology), Reus, 43201, Spain.
Montserrat PinentUniversitat Rovira i Virgili (Department of Biochemistry and Biotechnology), Tarragona, 43007, Spain. montserrat.pinent@urv.cat.
Anna ArdévolUniversitat Rovira i Virgili (Department of Biochemistry and Biotechnology), Tarragona, 43007, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sarcopenia, the progressive loss of skeletal muscle mass and function, represents a major public health concern due to its impact on mobility, independence, and quality of life, especially in oldadults. Current treatment strategies primarily rely on resistance training and nutritional support, with particular emphasis on adequate protein intake to stimulate muscle protein synthesis. In this review, we provide an overview of the pathophysiology of sarcopenia, with a focus on the molecular mechanisms underlying muscle atrophy and dysfunction. We explore the role of dietary protein as a cornerstone of sarcopenia management, highlighting current evidence on optimal protein sources and intake strategies. In addition, we examine other nutritional interventions, placing special emphasis on polyphenols, naturally occurring compounds known for their antioxidant and anti-inflammatory properties, which have shown promise in modulating pathways relevant to muscle preservation. Vitamin D and other nutritional supplements are also discussed in the context of their potential to support muscle health. Finally, we address emerging trends in the field, including targeting microbiota. By integrating current findings, this narrative review aims to provide a compilation of the evidence-based nutritional interventions for the prevention and management of sarcopenia.

Indexed as

Dietary ProteinsMuscle, SkeletalPolyphenolsSarcopeniaAgingAnimalsAntioxidantsDietary SupplementsHumansMuscle ProteinsAntioxidantsDietary ProteinsMuscle ProteinsPolyphenolsAgeingMusclePolyphenolProteinSarcopenia

Identifiers

PMID41697568
PMCPMC12909418

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.